Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Point-of-care Testing to Emerge as the Largest Segment in IVD

Nov 29, 2010
Share |
 
The global IVD services market represents one of the lucrative markets that will record strong growth in coming years. Point of care test segment is expected to play an important role in propelling the IVD industry in coming years. In fact, point-of-care test is expected to emerge as the largest consumer segment with ease of usage, time saving, and address security concerns of the consumers. New and advanced techniques will provide momentum to the POCT market. According to our research report “Global In Vitro Diagnostic Market Analysis”, the point-of-care diagnostics market is projected to grow at a CAGR of around 13% by 2012.
 
The global IVD services industry is already in a pivotal position to secure a significant share in the healthcare industry. With point-of-care testing, there are also other factors responsible for the bright prospects of the market like, prevalence of several chronic and infectious diseases, emergence of technologies in molecular diagnostics, and spreading awareness among health professionals and patients. Our report has also discussed market drivers driving growth in this industry. Besides, our report assists our clients in understanding opportunities and challenges before making any investment decision.
 
With the high prevalence of diabetes, cardiovascular diseases, and HIV/AIDS, the molecular diagnostic and clinical chemistry segments are expected to experience skyrocketing growth in coming years. Our report provides a detail analysis on clinical segmentation and segmentation by indication with their forecasted growth and factors behind their growth. The report has carefully examined the global IVD market in terms of industrial developments, competitive landscape, and regional basis to identify the potential growth segments.
 
Our study reveals that Europe was the largest IVD market in 2009, followed by North America and Japan. However, countries such as, China, India, Turkey, Brazil, and Mexico will become major players in near future. Our report has carefully examined the current and future scenario of the global IVD market by segmenting it into different regions. Under regional segmentation, the IVD market is classified into North America, Europe, and rest of the world.

For more information visit: http://www.rncos.com/Report/IM103.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports